glp-1 obesity drug news today october 16 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 therapies are changing obesity

doi:10.1371/journal.pone.0187836 225

Merck's Metabolic Disease Portfolio Mercks collaboration with Hansoh Pharma will enhance its portfolio in the growing areas of diabetes and obesity management

But reconstituted peptides last about 28-30 days in the refrigerator

The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)

The availability of semaglutide in different formulations, such as injections and oral tablets, provides patients with options that cater to their preferences

A separate Medicare GLP1 payment demonstration begins July 2026, under which eligible beneficiaries pay $50 per month for GLP1 medications